Entrepreneurial Orientation on Clinical Development in Pharmaceutical Industry: Fixed-Model Analysis

Business & Economics

• Pharmaceutical Industry 100%
• Entrepreneurial Orientation 83%
• Risk Taking 67%
• Biotech 42%
• Proactiveness 32%
• Pharmaceuticals 31%
• Innovativeness 24%
• Drugs 21%
• Expenses 19%
• R and D 18%
• Stock Volatility 16%
• Drug Development 15%
• Turnover 15%
• Management philosophy 14%
• Organizational Management 14%
• Fixed Effects Model 14%
• Management Capability 13%
• Panel Data Analysis 13%
• Large Firms 11%
• New Products 9%
• Panel Data 9%
• United States of America 5%
• Factors 4%

Engineering & Materials Science

• Drug products 83%
• Industry 33%
• Drug Development 21%
• Sales 14%